Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Focal Therapies (Laser Photocoagulation, Transpupillary Thermotherapy, Cryotherapy)
Treatment for Retinoblastoma
Typical Dosage: Not applicable
Effectiveness
90%
Safety Score
75%
Clinical Trials
0
Participants
0
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
75
DangerousModerateSafe
Treatment Details
Dosage Range
Not applicable
Time to Effect
immediate (full regression 2-4 weeks)
Treatment Duration
1-3 sessions
Evidence Quality
HIGHConfidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$200
Monitoring:$12,000
Side Effect Mgmt:$300
Total Annual:$12,500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
20
Outcome-Based Costs
Cost per Responder
$14,205
Cost per Remission
$14,205
Comparison vs Systemic Chemotherapy
Cost Difference
$-62,500/year
Less expensive
QALY Difference
+0.75 QALYs
Better outcomes
Dominance
DOMINATESBetter + cheaper
Focal Therapies (Laser Photocoagulation, Transpupillary Thermotherapy, Cryotherapy) Outcomes
for Retinoblastoma
Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+88%
Remission Rate
+88%
Common Side Effects
Local tissue damage (scarring)
+15%
Temporary vision changes
+10%
Retinal detachment
+1%
Vitreous hemorrhage
+1%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov